Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
See the Glossary of Defined Terms at the beginning of this Quarterly Report on Form 10-Q for terms used throughout this MD&A. Our MD&A is provided in addition to the accompanying condensed consolidated financial statements and footnotes to assist readers in understanding Pfizer’s results of operations, financial condition and cash flows. The MD&A is organized as follows:
Certain amounts in our MD&A may not add due to rounding. All percentages have been calculated using unrounded amounts.